search
Back to results

The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status (SOMNUS)

Primary Purpose

Delirium, Cognitive Impairment, Critically Ill

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sedation,RASS Targeted plus BIS Monitoring
Sedation, RASS Targeted
Sponsored by
Vanderbilt University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Delirium focused on measuring Delirium, Cognitive Impairment, Sleep, Polysomnography, Sedation, Mechanical Ventilation, Critical Illness

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male or female adult patients admitted to the ICU for critical illnesses requiring mechanical ventilation with expectation of being mechanically ventilated for greater than 24 hours. Subjects must have an actual or a target RASS of -3 or deeper with 48 hours of initiation of mechanical ventilation.

Exclusion Criteria:

  • Subjects who are less than 18 years old.
  • Inability to obtain informed consent from the patient or his/her surrogate.
  • Subjects admitted with alcohol or drug overdoses, suicide attempts, or alcohol/delirium with tremors.
  • Subjects with documented moderate to severe dementia.
  • Subjects with anoxic brain injuries, strokes, neurotrauma, or neuromuscular disorders such as myasthenia gravis or Guillain Barre syndrome.
  • Subjects whose family and/or physician have not committed to aggressive support for 72 hours or who are likely to withdraw within 72 hours.
  • Subjects who are moribund or are not expected to survive hospital discharge due to preexisting uncorrectable medical condition.
  • Subjects who have either Child-Pugh Class B or C cirrhosis.

Sites / Locations

  • Vanderbilt University Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Sedation, RASS Targeted

Sedation,RASS Targeted plus BIS Monitoring

Arm Description

Patient sedation utilizing standard of care methods (RASS Targeted)

Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring.

Outcomes

Primary Outcome Measures

Number of ventilator free hours and days

Secondary Outcome Measures

Number of delirium and coma free days
Incidence of subacute cognitive dysfunction using RBANS- Repeatable Battery for the Assessment of Neuropsychological Status,
Incidence of subacute cognitive dysfunction using TRAILS A&B
Incidence of subacute cognitive dysfunction using SF-36 - Short Form Health Survey
Incidence of subacute cognitive dysfunction using MMSE - Mini Mental State Examination
Incidence of subacute cognitive dysfunction using IADLs - instrumental activities of daily living
Incidence of subacute cognitive dysfunction using AD8- ADL - activities of daily living
Incidence of subacute cognitive dysfunction using APACHE II - Acute Physiologic and Chronic Health Evaluation II score
ICU length of stay
Hospital length of stay
Six month mortality
Biomarkers for neurological injury and inflammation, Neuron-Specific Enolase (NSE)
Biomarkers for neurological injury and inflammation, S100
Biomarkers for neurological injury and inflammation, IL-6
Biomarkers for neurological injury and inflammation, C Reactive Protein (CRP)
sleep quality
measured with continuous polysomnography

Full Information

First Posted
May 3, 2007
Last Updated
March 6, 2018
Sponsor
Vanderbilt University Medical Center
Collaborators
Medtronic - MITG
search

1. Study Identification

Unique Protocol Identification Number
NCT00469482
Brief Title
The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status
Acronym
SOMNUS
Official Title
A Randomized Control Trial Using the BIS Monitor to Avoid Over Sedation and Prolonged Neuropsychological Deficits in Mechanically Ventilated ICU Patients
Study Type
Interventional

2. Study Status

Record Verification Date
March 2018
Overall Recruitment Status
Completed
Study Start Date
June 2007 (undefined)
Primary Completion Date
October 2008 (Actual)
Study Completion Date
September 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center
Collaborators
Medtronic - MITG

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
A combined strategy of Richmond Agitation and Sedation Scale (RASS) clinical targeting plus bispectral index (BIS) guided sedation in mechanically ventilated, critically ill patients will decrease time on mechanical ventilation, decrease the duration of intensive care unit (ICU) delirium and coma, and will improve subacute neurocognitive function when compared to sedation guided by RASS targeting alone.
Detailed Description
Sedatives and analgesics are used to maintain comfort in almost all mechanically ventilated patients. Unfortunately, these medications also have many deleterious effects. Sedatives increase time on mechanical ventilation, have adverse hemodynamic effects, disturb sleep architecture, and have been determined to be an independent risk factor for ICU delirium. Delirium is an independent determinant of longer hospital stay, higher costs, and higher mortality, and the presence of delirium is highly predictive of long-term neurocognitive deficits. In consideration of these facts, better methods are needed to guide sedation, avoid oversedation, and possibly reduce delirium. Current guidelines recommend titration of sedation to a goal level based on bedside evaluation using a validated assessment tool, e.g. the Richmond Agitation and Sedation Scale. These assessment tools, however, are underused and many ICU patients are oversedated with well described consequences. A practical method by which to determine where a patient lies may prove beneficial in optimizing our delivery of sedatives and improving patient outcomes. While conventional EEG monitoring is not practical in the ICU, bispectral index (BIS) monitoring may be easily used in this clinical setting. BIS monitoring may provide a means to assess sedation level in unresponsive or paralyzed ICU patients and to decrease the total amount of sedatives/analgesics administered. Additional benefits of a combined clinical sedation scale and BIS-monitoring approach could include a decreased incidence and/or duration of delirium as well as a decreased incidence and severity of ICU-associated prolonged neurocognitive deficits. The specific aims of this study are as follows: Aim 1: To determine if sedative and analgesic medication delivery guided by clinical sedation scales and BIS monitor parameters of over-sedation will decrease time on mechanical ventilation. Aim 2: To determine if sedative and analgesic medication delivery guided by clinical sedation scales and BIS monitor parameters of over-sedation will decrease the duration of delirium and coma when compared to the use of clinical sedations scales alone. Aim 3: To determine if sedative and analgesic medication delivery guided by clinical sedation scales and BIS monitor parameters of over-sedation will decrease the incidence and severity of subacute cognitive impairment when compared to the use of clinical sedation scales alone. Aim 4: To characterize polysomnography findings in critically ill patients at various BIS levels. Aim 5: To determine if poor sleep quality is a factor in post critical illness neurocognitive dysfunction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium, Cognitive Impairment, Critically Ill
Keywords
Delirium, Cognitive Impairment, Sleep, Polysomnography, Sedation, Mechanical Ventilation, Critical Illness

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sedation, RASS Targeted
Arm Type
Active Comparator
Arm Description
Patient sedation utilizing standard of care methods (RASS Targeted)
Arm Title
Sedation,RASS Targeted plus BIS Monitoring
Arm Type
Active Comparator
Arm Description
Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring.
Intervention Type
Other
Intervention Name(s)
Sedation,RASS Targeted plus BIS Monitoring
Intervention Description
Providing patient sedation utilizing standard of care methods (RASS) plus BIS monitoring
Intervention Type
Other
Intervention Name(s)
Sedation, RASS Targeted
Intervention Description
Patient sedation utilizing standard of care methods (RASS targeted)
Primary Outcome Measure Information:
Title
Number of ventilator free hours and days
Time Frame
while in ICU, appoximately 3-7 days
Secondary Outcome Measure Information:
Title
Number of delirium and coma free days
Time Frame
while in ICU, appoximately 3-7 days)
Title
Incidence of subacute cognitive dysfunction using RBANS- Repeatable Battery for the Assessment of Neuropsychological Status,
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using TRAILS A&B
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using SF-36 - Short Form Health Survey
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using MMSE - Mini Mental State Examination
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using IADLs - instrumental activities of daily living
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using AD8- ADL - activities of daily living
Time Frame
3 months
Title
Incidence of subacute cognitive dysfunction using APACHE II - Acute Physiologic and Chronic Health Evaluation II score
Time Frame
3 months
Title
ICU length of stay
Time Frame
while in ICU, appoximately 3-7 days
Title
Hospital length of stay
Time Frame
while in hospital, usually 5-10 days
Title
Six month mortality
Time Frame
6 months
Title
Biomarkers for neurological injury and inflammation, Neuron-Specific Enolase (NSE)
Time Frame
Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)
Title
Biomarkers for neurological injury and inflammation, S100
Time Frame
Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)
Title
Biomarkers for neurological injury and inflammation, IL-6
Time Frame
Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)
Title
Biomarkers for neurological injury and inflammation, C Reactive Protein (CRP)
Time Frame
Baseline, Day 3 and at Ventilator removal (appoximately day 3-7)
Title
sleep quality
Description
measured with continuous polysomnography
Time Frame
within 24 hours of enrollment through day 3-7

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male or female adult patients admitted to the ICU for critical illnesses requiring mechanical ventilation with expectation of being mechanically ventilated for greater than 24 hours. Subjects must have an actual or a target RASS of -3 or deeper with 48 hours of initiation of mechanical ventilation. Exclusion Criteria: Subjects who are less than 18 years old. Inability to obtain informed consent from the patient or his/her surrogate. Subjects admitted with alcohol or drug overdoses, suicide attempts, or alcohol/delirium with tremors. Subjects with documented moderate to severe dementia. Subjects with anoxic brain injuries, strokes, neurotrauma, or neuromuscular disorders such as myasthenia gravis or Guillain Barre syndrome. Subjects whose family and/or physician have not committed to aggressive support for 72 hours or who are likely to withdraw within 72 hours. Subjects who are moribund or are not expected to survive hospital discharge due to preexisting uncorrectable medical condition. Subjects who have either Child-Pugh Class B or C cirrhosis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Wes Ely, MD
Organizational Affiliation
Vanderbilt Universtiy
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vanderbilt University Medical Center
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37232
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
7966844
Citation
Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, Katz N, Cook EF, Orav EJ, Lee TH. The relationship of postoperative delirium with psychoactive medications. JAMA. 1994 Nov 16;272(19):1518-22.
Results Reference
background
PubMed Identifier
16394685
Citation
Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006 Jan;104(1):21-6. doi: 10.1097/00000542-200601000-00005.
Results Reference
background
PubMed Identifier
10335730
Citation
Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med. 1999 May;106(5):565-73. doi: 10.1016/s0002-9343(99)00070-4.
Results Reference
background
PubMed Identifier
11511942
Citation
Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001 Aug;27(8):1297-304. doi: 10.1007/s001340101017.
Results Reference
background
PubMed Identifier
8596223
Citation
Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA. 1996 Mar 20;275(11):852-7.
Results Reference
background
PubMed Identifier
11797025
Citation
Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001 Dec;27(12):1892-900. doi: 10.1007/s00134-001-1132-2. Epub 2001 Nov 8.
Results Reference
background
PubMed Identifier
15082703
Citation
Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62. doi: 10.1001/jama.291.14.1753.
Results Reference
background
PubMed Identifier
15071384
Citation
Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004 Apr;32(4):955-62. doi: 10.1097/01.ccm.0000119429.16055.92.
Results Reference
background
PubMed Identifier
15264710
Citation
Jackson JC, Gordon SM, Hart RP, Hopkins RO, Ely EW. The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev. 2004 Jun;14(2):87-98. doi: 10.1023/b:nerv.0000028080.39602.17.
Results Reference
background
PubMed Identifier
11902253
Citation
Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ, Peruzzi WT, Lumb PD; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 Jan;30(1):119-41. doi: 10.1097/00003246-200201000-00020. No abstract available. Erratum In: Crit Care Med 2002 Mar;30(3):726.
Results Reference
background
PubMed Identifier
9726743
Citation
Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998 Aug;114(2):541-8. doi: 10.1378/chest.114.2.541.
Results Reference
background
PubMed Identifier
10816184
Citation
Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 May 18;342(20):1471-7. doi: 10.1056/NEJM200005183422002.
Results Reference
background
PubMed Identifier
3921096
Citation
Aurell J, Elmqvist D. Sleep in the surgical intensive care unit: continuous polygraphic recording of sleep in nine patients receiving postoperative care. Br Med J (Clin Res Ed). 1985 Apr 6;290(6474):1029-32. doi: 10.1136/bmj.290.6474.1029.
Results Reference
background
PubMed Identifier
10713011
Citation
Cooper AB, Thornley KS, Young GB, Slutsky AS, Stewart TE, Hanly PJ. Sleep in critically ill patients requiring mechanical ventilation. Chest. 2000 Mar;117(3):809-18. doi: 10.1378/chest.117.3.809. Erratum In: Chest 2001 Mar;119(3):993.
Results Reference
background
PubMed Identifier
10072023
Citation
Sleigh JW, Andrzejowski J, Steyn-Ross A, Steyn-Ross M. The bispectral index: a measure of depth of sleep? Anesth Analg. 1999 Mar;88(3):659-61. doi: 10.1097/00000539-199903000-00035.
Results Reference
background
PubMed Identifier
11547323
Citation
Grocott HP, Newman MF, El-Moalem H, Bainbridge D, Butler A, Laskowitz DT. Apolipoprotein E genotype differentially influences the proinflammatory and anti-inflammatory response to cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2001 Sep;122(3):622-3. doi: 10.1067/mtc.2001.115152. No abstract available.
Results Reference
background
PubMed Identifier
10719986
Citation
Weigand MA, Volkmann M, Schmidt H, Martin E, Bohrer H, Bardenheuer HJ. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology. 2000 Mar;92(3):905-7. doi: 10.1097/00000542-200003000-00057. No abstract available.
Results Reference
background
PubMed Identifier
10390379
Citation
Hopkins RO, Weaver LK, Pope D, Orme JF, Bigler ED, Larson-LOHR V. Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Jul;160(1):50-6. doi: 10.1164/ajrccm.160.1.9708059.
Results Reference
background
PubMed Identifier
11825238
Citation
Norris PR, Dawant BM. Closing the loop in ICU decision support: physiologic event detection, alerts, and documentation. Proc AMIA Symp. 2001:498-502.
Results Reference
background
Links:
URL
http://www.ICUdelirium.org
Description
This is an educational website about ICU delirium.

Learn more about this trial

The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status

We'll reach out to this number within 24 hrs